You may also report side effects to Genentech at (888) 835-2555.
Get help paying for your Vabysmo prescription
SUPPORT
Genentech Patient Resource Center Our center dedicated to getting patients and caregivers to the right resources. Call us at (877) 436-3683 or (877) GENENTECH, Monday-Friday, 6am-5pm PT.
Genentech Access Solutions This service offers coverage support, patient assistance, and other useful information.
Genentech Patient Foundation Provides free medicine to patients without insurance coverage or who can't pay for their Genentech medicine.
RESOURCES
Vabysmo.com Provides additional resources and information.
Get answers to your questions about your Vabysmo prescription
SUPPORT
Medicine Information Support Ask about possible side effects and any other medical questions related to your prescribed Genentech medicine.
Vabysmo.com Provides additional resources and information.
What it Treats
What is VABYSMO?
VABYSMO (faricimab-svoa) is a prescription medicine given by injection into the eye, used to treat adults with Neovascular (Wet) Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME).
Important Safety Information
Do not receive VABYSMO if you:
have an infection in or around your eye.
have active swelling around your eye that may include pain and redness.
are allergic to VABYSMO or any of the ingredients in VABYSMO.
What is the most important information I should know about VABYSMO?
Injections like the one for VABYSMO can cause an eye infection (endophthalmitis) or separationof layers of the retina (retinal detachment). Call your healthcare provider right away if you have increasing eye pain, vision loss, sensitivity to light, or redness in the white of the eye.
VABYSMO may cause a temporary increase in pressure in the eye (intraocular pressure), which occurs within 60 minutes after receiving the eye injection.
Although not common, VABYSMO patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes (thromboembolic events). In clinical studies forwet AMD during the first year, 7 out of 664 patients treated with VABYSMO reported such an event. In DME studies from baseline to week 100, 64 out of 1,262 patients treated with VABYSMO reported such an event.
Before receiving VABYSMO, tell your healthcare provider about all of your medical conditions, including if you:
Are pregnant or plan to become pregnant. Based on how VABYSMO interacts with your body,there may be a potential risk to your unborn baby. You should use birth control before your first injection, during your treatment with VABYSMO, and for 3 months after your last dose of VABYSMO.
Are breastfeeding or plan to breastfeed. It is not known if VABYSMO passes into your breastmilk. Talk to your healthcare provider about the best way to feed your baby if you receive VABYSMO.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What should I avoid while receiving VABYSMO?
Your vision may be impaired after receiving an eye injection or after an eye exam; do not drive or use machinery until your vision has recovered sufficiently.
What are the most common side effects with VABYSMO?
The most common side effects with VABYSMO were cataract and blood on the white of the eye (conjunctival hemorrhage).
These are not all the possible side effects of VABYSMO.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555.
Please see the VABYSMO full Prescribing Information for additional Important Safety Information.